Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substantially pure apraclonidine

Substantially pure apraclonidine

US Patent 5612364 · Granted Mar 18, 1997

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for treating pruritus2025
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-relat2017
RNAi-mediated inhibition of histamine receptor H1-related conditions2017
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-relat2016
RNAi-mediated inhibition of tumor necrosis factor α-related conditions2016
RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditio2016
RNAi-mediated inhibition of histamine receptor H1-related conditions2015
Compositions containing moxifloxacin for treating otic infections2015
RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditio2014
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-relat2014
Method of treating otic infections with moxifloxacin compositions2014
RNAi-mediated inhibition of histamine receptor H1-related conditions2013